Endocrinology and Metabolism

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Effects of Vildagliptin or Pioglitazone on Glycemic Variability and Oxidative Stress in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A 16-Week, Randomised, Open Label, Pilot Study

Nam Hoon Kim, Dong-Lim Kim, Kyeong Jin Kim, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Sin Gon Kim

Endocrinol Metab. 2017;32(2):241-247. Published online June 23, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.2.241

Nam Hoon Kim, Dong-Lim Kim, Kyeong Jin Kim, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Sin Gon Kim

Endocrinology and Metabolism. 2017;32(2):241

Link1 Link2 Link3

A 16-week study to compare the effect of vildagliptin versus gliclazide on postprandial lipoprotein concentrations and oxidative stress in patients with type 2 diabetes inadequately controlled with metformin monotherapy

Marcelo R. Nasser Hissa, Lilian Loureiro Albuquerque Cavalcante, Sergio Botelho Guimarães, Miguel Nasser Hissa

Diabetology & Metabolic Syndrome. 2015;7(1):

Link1

Link2 Link3 Link4

Effects of replacing metformin with pioglitazone on glycemic control in japanese patients with poorly controlled type 2 diabetes mellitus: A 12-week, open-label, prospective study

Shinji Sakaue, Mitsunori Kamigaki, Haruhiko Yoshimura, Masaharu Nishimura

Current Therapeutic Research. 2008;69(4):364-377

Link1 Link2

Abstract #805111: Effects of Hydroxychloroquine 400 MG or Teneligliptin 20 MG on Glycemic Variability In Patients with Type 2 Diabetes Inadequately Controlledwith Insulin Plus Oral Therapy: A 12-Week, Randomised Pilot Study

Amit Gupta

Endocrine Practice. 2020;26:116

Link1 Link2

Treatment Compliance with Fixed-Dose Combination of Vildagliptin/Metformin in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy: A 24-Week Observational Study

Grigorios Rombopoulos, Magdalini Hatzikou, Athanasios Athanasiadis, Moyses Elisaf

International Journal of Endocrinology. 2015;2015:1-5

Link1

Link2 Link3

Comparison of vildagliptin and pioglitazone in patients with type 2 diabetes inadequately controlled with metformin

G. Bolli, F. Dotta, L. Colin, B. Minic, M. Goodman

Diabetes, Obesity and Metabolism. 2009;11(6):589-595

Link1 Link2

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

E. Ferrannini, V. Fonseca, B. Zinman, D. Matthews, B. Ahrén, S. Byiers, Q. Shao, S. Dejager

Diabetes, Obesity and Metabolism. 2009;11(2):157-166

Link1 Link2

A comparison of efficacy and safety of vildagliptin and gliclazide in combination with metformin in patients with Type 2 diabetes inadequately controlled with metformin alone: a 52-week, randomized study

C. Filozof, J.-F. Gautier

Diabetic Medicine. 2010;27(3):318-326

Link1 Link2

Effects of Acarbose Versus Glibenclamide on Glycemic Excursion and Oxidative Stress in Type 2 Diabetic Patients Inadequately Controlled by Metformin: A 24-Week, Randomized, Open-Label, Parallel-Group Comparison

Jun-Sing Wang, Shi-Dou Lin, Wen-Jane Lee, Shih-Li Su, I-Te Lee, Shih-Te Tu, Yao-Hsien Tseng, Shih-Yi Lin, Wayne Huey-Herng Sheu

Clinical Therapeutics. 2011;33(12):1932-1942

Link1 Link2

Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin uptitration in Chinese patients with type 2 diabetes inadequately controlled with metformin monotherapy: a randomized, open-label, prospective study (VISION)

L.-N. Ji, C.-Y. Pan, J.-M. Lu, H. Li, D.-L. Zhu, Q. Li, Q.-F. Li, Y.-D. Peng, H.-M. Tian, C. Yao, Z.-G. Zhao, L. Wang, B.-H. Wang,

Diabetes, Obesity and Metabolism. 2016;18(8):775-782

Link1 Link2